Pankti Reid to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Pankti Reid has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.053
-
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug Saf. 2023 11; 46(11):1049-1071.
Score: 0.053
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.